Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 12
2004 18
2005 13
2006 8
2007 9
2008 11
2009 8
2010 11
2011 19
2012 19
2013 19
2014 22
2015 23
2016 13
2017 13
2018 17
2019 24
2020 17
2021 23
2022 22
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Results by year

Filters applied: . Clear all
Page 1
[Double extrahepatic bile duct with pancreaticobiliary maljunction:a case report].
Mori Y, Hasegawa H, Fukasawa M, Takano S, Shindo H, Takahashi E, Shimamura N, Hosomura N, Kawaida H, Enomoto N. Mori Y, et al. Among authors: enomoto n. Nihon Shokakibyo Gakkai Zasshi. 2024;121(4):321-329. doi: 10.11405/nisshoshi.121.321. Nihon Shokakibyo Gakkai Zasshi. 2024. PMID: 38599843 Japanese.
A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population.
Yoshimura D, Fukasawa M, Yoda Y, Ohtaka M, Ooka T, Takano S, Kawakami S, Fukasawa Y, Kuratomi N, Harai S, Shimamura N, Hasegawa H, Imagawa N, Suzuki Y, Yoshida T, Kobayashi S, Sato M, Yamaguchi T, Maekawa S, Enomoto N. Yoshimura D, et al. Among authors: enomoto n. Diagnostics (Basel). 2024 Mar 20;14(6):651. doi: 10.3390/diagnostics14060651. Diagnostics (Basel). 2024. PMID: 38535071 Free PMC article.
A Novel Method of Calculating the Drained Liver Volume Using a 3D Volume Analyzer for Biliary Drainage of Unresectable Malignant Hilar Biliary Obstruction.
Imagawa N, Fukasawa M, Takano S, Kawakami S, Fukasawa Y, Hasegawa H, Kuratomi N, Harai S, Shimamura N, Yoshimura D, Kobayashi S, Yoshida T, Sato M, Suzuki Y, Enomoto N. Imagawa N, et al. Among authors: enomoto n. Dig Dis Sci. 2024 Mar;69(3):969-977. doi: 10.1007/s10620-024-08294-z. Epub 2024 Feb 1. Dig Dis Sci. 2024. PMID: 38300418 Free PMC article. Review.
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
Tahata Y, Hikita H, Mochida S, Enomoto N, Ido A, Kuroda H, Miki D, Kurosaki M, Hiasa Y, Sakamori R, Kawada N, Yamashita T, Suda G, Yatsuhashi H, Yoshiji H, Kato N, Takami T, Nakao K, Matsuura K, Asahina Y, Itoh Y, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Ueno Y, Akuta N, Miyazaki M, Nozaki Y, Kabayama M, Sobue S, Moriuchi A, Miyaki T, Kodama T, Tatsumi T, Yamada T, Takehara T. Tahata Y, et al. Among authors: enomoto n. J Gastroenterol. 2023 Dec;58(12):1211-1221. doi: 10.1007/s00535-023-02039-x. Epub 2023 Oct 13. J Gastroenterol. 2023. PMID: 37831182 Free PMC article.
Correction: Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.
Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, Sato K, Shiotani A, Naito Y, Fujikawa Y, Hokari R, Masaoka T, Fujimoto K, Kaneko H, Torii A, Matsueda K, Miwa H, Enomoto N, Shimosegawa T, Koike K. Fukudo S, et al. Among authors: enomoto n. J Gastroenterol. 2023 Nov;58(11):1165. doi: 10.1007/s00535-023-02044-0. J Gastroenterol. 2023. PMID: 37752291 Free PMC article. No abstract available.
Significance of the autoantibody assay in predicting the development of immune-related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Muraoka M, Suzuki Y, Sato M, Kobayashi S, Yoshida T, Takano S, Maekawa S, Enomoto N. Takada H, et al. Among authors: enomoto n. Hepatol Res. 2024 Feb;54(2):162-173. doi: 10.1111/hepr.13969. Epub 2023 Oct 6. Hepatol Res. 2024. PMID: 37740643
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.
Fujii H, Suzuki Y, Sawada K, Tatsuta M, Maeshiro T, Tobita H, Tsutsumi T, Akahane T, Hasebe C, Kawanaka M, Kessoku T, Eguchi Y, Syokita H, Nakajima A, Kamada T, Yoshiji H, Kawaguchi T, Sakugawa H, Morishita A, Masaki T, Ohmura T, Watanabe T, Kawada N, Yoda Y, Enomoto N, Ono M, Fuyama K, Okada K, Nishimoto N, Ito YM, Kamada Y, Takahashi H, Sumida Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: enomoto n. Hepatol Res. 2023 Nov;53(11):1059-1072. doi: 10.1111/hepr.13947. Epub 2023 Aug 28. Hepatol Res. 2023. PMID: 37537735
300 results